Details of Drug

Drug General Information (ID: D1343)
Drug Name	Procainamide
Drug Type	Small molecule
Drug Synonymous	Biocoryl; Novocainamid; Novocainamide; Novocamid; Procainamida; Procainamidum; Procamide; Procan; Procanbid; Procapan; Pronestyl; Novocaine amide; Procaine amide; P-Aminobenzoic diethylaminoethylamide; Procainamida [INN-Spanish]; Procainamide (INN); Procainamide [INN:BAN]; Procainamidum [INN-Latin]; Procan (TN); Procanbid (TN); Procapan (free base); Pronestyl (TN); Pronestyl-Sr; P-Amino-N-(2-diethylaminoethyl)benzamide; Benzamide, 4-amino-N-(2-(diethylamino)ethyl)-(9CI); 2-Diethylaminoethylamid kyseliny p-aminobenzoove; 2-Diethylaminoethylamid kyseliny p-aminobenzoove [Czech]; 4-Amino-N-(2-(Diethylamino)Ethyl)Benzamide Sulfate; 4-Amino-N-(2-(diethylamino)ethyl)benzamide; 4-Amino-N-[2-(diethylamino)ethyl]benzamide; 4-amino-N-(2-diethylaminoethyl)-benzamide; 4-amino-N-(2-diethylaminoethyl)benzamide Click to Show/Hide
Disease Class	BC71: Ventricular tachyarrhythmia
Therapeutic Class	Antiarrhythmic Agents
Structure
Structure	3D Structure		2D Structure
Formula	C13H21N3O
InChI	1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)
InChIKey	REQCZEXYDRLIBE-UHFFFAOYSA-N
Canonical SMILES	CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
External Link
	Pubchem ID	4913
	CAS Number	18788
	CHEBI ID	8428
	TTD ID	D0U5SI
	VARIDT ID	DR00292

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM003 Affected organization distribution AM004 Affected intra/extra-hepatic metabolism AM005 Affected excretion pathways AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM003 Complex formation BM014 Interference of cell/tissue uptake BM016 Altered formation of CYP450 enzymes BM018 Non-CYP450 enzyme inhibition BM028 Competitive inhibition of renal tubular secretion BM033 Additive anticholinergic effects BM035 Additive antimotility effects BM043 Additive immunosuppressive effects BM044 Additive myelosuppressive effects BM045 Additive neuromuscular blocking effects BM049 Increased risk of atrioventricular block BM051 Increased risk of bradycardia BM076 Increased risk of prolong QT interval BM078 Increased risk of rapid heart rate BM081 Increased risk of ventricular arrhythmias BM091 Antagonize the effect of cholinergic agents BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Procainamide
Affected gastrointestinal absorption
	Complex formation					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0381		Colesevelam	C31H67Cl3N4O	160051	Moderate		Inter Info	[1], [196]
Affected organization distribution
	Interference of cell/tissue uptake					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1817		Indium In-111 oxyquinoline	C27H18InN3O3	16685037	Moderate		Inter Info	[243]
D1906		Thallous Chloride	ClTl	24642	Moderate		Inter Info	[2], [251], [252]
Affected intra/extra-hepatic metabolism
	Altered formation of CYP450 enzymes					Drug Num: 18
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0023		Adalimumab	NA	NA	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D0032		Alefacept	NA	NA	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D0085		Anakinra	C20H23N5O7S2	146171046	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D0614		Etanercept	NA	NA	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D0802		Infliximab	NA	NA	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D0246		Canakinumab	NA	NA	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D0304		Certolizumab pegol	NA	NA	Moderate		Inter Info	[172], [174], [179]
D0564		Emapalumab	NA	NA	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D0736		Golimumab	NA	NA	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D0747		Guselkumab	NA	NA	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D0875		Ixekizumab	NA	NA	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D1403		Rilonacept	NA	NA	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D1447		Sarilumab	NA	NA	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D1448		Satralizumab	NA	NA	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D1454		Secukinumab	NA	NA	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D1467		Siltuximab	NA	NA	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D1599		Tocilizumab	NA	NA	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D1671		Ustekinumab	NA	NA	Moderate		Inter Info	[3], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
	Non-CYP450 enzyme inhibition					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0043		Alosetron	C17H18N4O	2099	Minor		Inter Info	[271]
Affected excretion pathways
	Competitive inhibition of renal tubular secretion					Drug Num: 11
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1165		Ofloxacin	C18H20FN3O4	4583	Major		Inter Info	[115], [45]
D0337		Cimetidine	C10H16N6S	2756	Moderate		Inter Info	[189], [190], [191], [192], [193], [194]
D0576		Entecavir	C12H15N5O3	135398508	Moderate		Inter Info	[211]
D1015		Metformin	C4H11N5	4091	Moderate		Inter Info	[230], [231]
D1241		Pemetrexed	C20H21N5O6	135410875	Moderate		Inter Info	[235]
D1381		Ranitidine	C13H22N4O3S	3001055	Moderate		Inter Info	[264], [265], [193], [266]
D1382		Ranitidine (bismuth citrate)	C13H22N4O3S	3001055	Moderate		Inter Info	[264], [193], [266]
D1645		Trimethoprim	C14H18N4O3	5578	Moderate		Inter Info	[267], [268], [269]
D1656		Trospium	C25H30NO3+	5284632	Moderate		Inter Info	[3], [253], [270]
D1061		Midodrine	C12H18N2O4	4195	Minor		Inter Info	[278]
D0998		Memantine	C12H21N	4054	Minor		Inter Info	[70], [71], [279]
Pharmacodynamic additive effects
	Additive anticholinergic effects					Drug Num: 8
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0733		Glycopyrronium	C19H28NO3+	3494	Moderate		Inter Info	[218], [219], [220]
D0734		Glycopyrronium (topical)	C19H28NO3+	3494	Moderate		Inter Info	[218], [219], [220]
D0842		Ipratropium	C20H30NO3+	657309	Moderate		Inter Info	[221], [218], [222], [219], [220], [223], [224], [225]
D0019		Aclidinium	C26H30NO4S2+	11434515	Moderate		Inter Info	[221], [218], [222], [219], [220], [223], [224], [225]
D1396		Revefenacin	C35H43N5O4	11753673	Moderate		Inter Info	[221], [218], [222], [219], [220], [223], [224], [225]
D1590		Tiotropium	C19H22NO4S2+	5487427	Moderate		Inter Info	[221], [218], [222], [219], [220], [223], [224], [225]
D1665		Umeclidinium	C29H34NO2+	11519070	Moderate		Inter Info	[221], [218], [222], [219], [220], [223], [224], [225]
D0843		Ipratropium (nasal)	C20H30NO3+	657309	Minor		Inter Info	[272], [273], [274]
	Additive antimotility effects					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0947		Loperamide	C29H33ClN2O2	3955	Moderate		Inter Info	[229]
	Additive immunosuppressive effects					Drug Num: 7
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0348		Cladribine	C10H12ClN5O3	20279	Major		Inter Info	[3], [63]
D0146		Baricitinib	C16H17N7O2S	44205240	Major		Inter Info	[2], [3], [96]
D1666		Upadacitinib	C17H19F3N6O	58557659	Major		Inter Info	[139]
D0033		Alemtuzumab	NA	NA	Moderate		Inter Info	[183]
D1162		Ocrelizumab	NA	NA	Moderate		Inter Info	[247]
D1174		Omacetaxine mepesuccinate	C29H39NO9	285033	Moderate		Inter Info	[248]
D1375		Radium Ra 223 dichloride	NA	NA	Moderate		Inter Info	[249]
	Additive myelosuppressive effects					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0370		Clozapine	C18H19ClN4	135398737	Major		Inter Info	[64], [8], [11], [12]
D0433		Deferiprone	C7H9NO2	2972	Major		Inter Info	[2], [98], [99]
D0710		Ganciclovir	C9H13N5O4	135398740	Moderate		Inter Info	[2], [3], [216], [217]
D1676		Valganciclovir	C14H22N6O5	135413535	Moderate		Inter Info	[2], [3], [216], [217]
	Additive neuromuscular blocking effects					Drug Num: 6
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0343		Cisatracurium	C53H72N2O12+2	62887	Moderate		Inter Info	[187], [195]
D0122		Atracurium	C53H72N2O12+2	47319	Moderate		Inter Info	[187], [195]
D1080		Mivacurium	C58H80N2O14+2	5281042	Moderate		Inter Info	[187], [195]
D1219		Pancuronium	C35H60N2O4+2	441289	Moderate		Inter Info	[187], [195]
D1420		Rocuronium	C32H53N2O4+	441290	Moderate		Inter Info	[187], [195]
D1510		Succinylcholine	C14H30N2O4+2	5314	Minor		Inter Info	[280]
	Increased risk of atrioventricular block					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0066		Amiodarone	C25H29I2NO3	2157	Major		Inter Info	[90], [91], [92]
D0885		Lacosamide	C13H18N2O3	219078	Moderate		Inter Info	[244]
	Increased risk of bradycardia					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1163		Octreotide	C49H66N10O10S2	448601	Moderate		Inter Info	[232], [233]
D0891		Lanreotide	C54H69N11O10S2	71349	Moderate		Inter Info	[232], [233]
D1600		Tofacitinib	C16H20N6O	9926791	Moderate		Inter Info	[2], [253]
	Increased risk of prolong QT interval					Drug Num: 184
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0003		Abarelix	C72H95ClN14O14	16131215	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0036		Alfuzosin	C19H27N5O4	2092	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0068		Amitriptyline	C20H23N	2160	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0072		Amoxapine	C17H16ClN3O	2170	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0084		Anagrelide	C10H7Cl2N3O	135409400	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0097		Apomorphine	C17H17NO2	6005	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0115		Astemizole	C28H31FN4O	2247	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0119		Atomoxetine	C17H21NO	54841	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0139		Azithromycin	C38H72N2O12	447043	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0320		Chloroquine	C18H26ClN3	2719	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0324		Chlorpromazine	C17H19ClN2S	2726	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Major		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57]
D0342		Cisapride	C23H29ClFN3O4	6917698	Major		Inter Info	[1], [2], [3], [18], [58], [59]
D0345		Citalopram	C20H21FN2O	2771	Major		Inter Info	[1], [2], [3], [60], [61], [13], [62]
D0358		Clofazimine	C27H22Cl2N4	2794	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0429		Daunorubicin	C27H29NO10	30323	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0430		Daunorubicin (liposomal)	C27H29NO10	30323	Major		Inter Info	[1], [7], [12]
D0467		Dextropropoxyphene	C22H29NO2	10100	Major		Inter Info	[1], [7], [12]
D0508		Disopyramide	C21H29N3O	3114	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0513		Dofetilide	C19H27N3O5S2	71329	Major		Inter Info	[65]
D0514		Dolasetron	C19H20N2O3	3033818	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0528		Doxorubicin	C27H29NO11	31703	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0529		Doxorubicin (liposomal)	C27H29NO11	31703	Major		Inter Info	[1], [7], [12]
D0535		Droperidol	C22H22FN3O2	3168	Major		Inter Info	[1], [2], [3], [66], [67], [13]
D0554		Efavirenz	C14H9ClF3NO2	64139	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0584		Epirubicin	C27H29NO11	41867	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0597		Erythromycin	C37H67NO13	12560	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0676		Fluoxetine	C17H18F3NO	3386	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0678		Fluphenazine	C22H26F3N3OS	3372	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0682		Flutamide	C11H11F3N2O3	3397	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0694		Foscarnet	CH3O5P	3415	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0737		Goserelin	C59H84N18O14	5311128	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0738		Granisetron	C18H24N4O	5284566	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0740		Grepafloxacin	C19H22FN3O3	72474	Major		Inter Info	[22], [1], [2], [3], [68], [69], [54]
D0750		Haloperidol	C21H23ClFNO2	3559	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0781		Hydroxyzine	C21H27ClN2O2	3658	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0787		Ibutilide	C20H36N2O3S	60753	Major		Inter Info	[70], [71], [72]
D0795		Imipramine	C19H24N2	3696	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0908		Leuprolide	C59H84N16O12	657181	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0943		Lomefloxacin	C17H19F2N3O3	3948	Major		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57]
D0979		Maprotiline	C20H23N	4011	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0992		Mefloquine	C17H16F6N2O	4046	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1010		Mesoridazine	C21H26N2OS2	4078	Major		Inter Info	[1], [2], [3], [73], [13]
D1017		Methadone	C21H27NO	4095	Major		Inter Info	[1], [2], [3], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [13]
D1063		Mifepristone	C29H35NO2	55245	Major		Inter Info	[1], [2], [3], [84]
D1075		Mirtazapine	C17H19N3	4205	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1092		Moxifloxacin	C21H24FN3O4	152946	Major		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57]
D1137		Nilutamide	C12H10F3N3O4	4493	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1158		Nortriptyline	C19H21N	4543	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1181		Ondansetron	C18H19N3O	4595	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1210		Oxytocin	C43H66N12O12S2	439302	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1216		Palonosetron	C19H24N2O	6337614	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1246		Pentamidine	C19H24N4O2	4735	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1254		Perflutren	C3F8	6432	Major		Inter Info	[88], [89]
D1257		Perphenazine	C21H26ClN3OS	4748	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0007		Abiraterone	C24H31NO	132971	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0037		Alimemazine	C18H22N2S	5574	Major		Inter Info	[1], [7], [12]
D0067		Amisulpride	C17H27N3O4S	2159	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0095		Apalutamide	C21H15F4N5O2S	24872560	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0112		Asenapine	C17H16ClNO	3036780	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0170		Bepridil	C24H34N2O	2351	Major		Inter Info	[97], [10]
D0180		Bicalutamide	C18H14F4N2O4S	2375	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0230		Cabozantinib	C28H24FN3O5	25102847	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0336		Cilostazol	C20H27N5O2	2754	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0349		Clarithromycin	C38H69NO13	84029	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0361		Clomipramine	C19H23ClN2	2801	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0437		Degarelix	C82H103ClN18O16	16136245	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0446		Desipramine	C18H22N2	2995	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0452		Deutetrabenazine	C19H27NO3	73437646	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0525		Doxepin	C19H21NO	667477	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0526		Doxepin (topical)	C19H21NO	667477	Major		Inter Info	[1], [7], [12]
D0534		Dronedarone	C31H44N2O5S	208898	Major		Inter Info	[1], [2], [3], [100]
D0559		Eliglustat	C23H36N2O4	23652731	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0577		Entrectinib	C31H34F2N6O2	25141092	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0594		Eribulin	C40H59NO11	11354606	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0599		Escitalopram	C20H21FN2O	146570	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0632		Ezogabine	C16H18FN3O2	121892	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[70], [101], [102]
D0664		Flecainide	C17H20F6N2O3	3356	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0700		Fostemsavir	C25H26N7O8P	11319217	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0712		Gatifloxacin	C19H22FN3O4	5379	Major		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Major		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57]
D0720		Gilteritinib	C29H44N8O3	49803313	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0725		Glasdegib	C21H22N6O	25166913	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0749		Halofantrine	C26H30Cl2F3NO	37393	Major		Inter Info	[103], [1], [2], [3], [104], [105], [106], [107], [108]
D0751		Halothane	C2HBrClF3	3562	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0758		Histrelin	C66H86N18O12	25077993	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0788		Idarubicin	C26H27NO9	42890	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0791		Iloperidone	C24H27FN2O4	71360	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0806		Inotuzumab ozogamicin	NA	NA	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0899		Lefamulin	C28H45NO5S	25185057	Major		Inter Info	[111]
D0903		Lenvatinib	C21H19ClN4O4	9823820	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0909		Levacetylmethadol	C23H31NO2	15130	Major		Inter Info	[3], [112], [13]
D0919		Levofloxacin	C18H20FN3O4	149096	Major		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57]
D0937		Lisdexamfetamine	C15H25N3O	11597698	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0940		Lithium carbonate	CLi2O3	11125	Major		Inter Info	[1], [7], [12]
D0942		Lofexidine	C11H12Cl2N2O	30668	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0948		Lopinavir	C37H48N4O5	92727	Major		Inter Info	[1], [7], [12]
D0960		Lumefantrine	C30H32Cl3NO	6437380	Major		Inter Info	[2], [3], [113]
D0965		Macimorelin	C26H30N6O3	9804938	Major		Inter Info	[114]
D1026		Methotrimeprazine	C19H24N2OS	72287	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1062		Midostaurin	C35H30N4O4	9829523	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1136		Nilotinib	C28H22F3N7O	644241	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1155		Norfloxacin	C16H18FN3O3	4539	Major		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57]
D1169		Oliceridine	C22H30N2O2S	66553195	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1189		Osilodrostat	C13H10FN3	44139752	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1190		Osimertinib	C28H33N7O2	71496458	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1215		Paliperidone	C23H27FN4O3	115237	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1221		Panobinostat	C21H23N3O2	6918837	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1223		Papaverine	C20H21NO4	4680	Major		Inter Info	[116], [117], [118], [119], [120], [121], [122], [123]
D1230		Pasireotide	C58H66N10O9	9941444	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1232		Pazopanib	C21H23N7O2S	10113978	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1290		Pimavanserin	C25H34FN3O2	10071196	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1292		Pimozide	C28H29F2N3O	16362	Major		Inter Info	[3], [66], [127], [13]
D1302		Pitolisant	C17H26ClNO	9948102	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1315		Posaconazole	C37H42F2N8O4	468595	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1339		Primaquine	C15H21N3O	4908	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1342		Probucol	C31H48O2S2	4912	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1352		Promethazine	C17H20N2S	4927	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1353		Propafenone	C21H27NO3	4932	Major		Inter Info	[128], [129], [130], [131], [132], [133]
D1368		Quetiapine	C21H25N3O2S	5002	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1388		Relugolix	C29H27F2N7O5S	10348973	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1398		Ribociclib	C23H30N8O	44631912	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1404		Rilpivirine	C22H18N6	6451164	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1424		Romidepsin	C24H36N4O6S2	5352062	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1444		Saquinavir	C38H50N6O5	441243	Major		Inter Info	[134], [135], [1], [2], [3], [136], [137]
D1459		Selpercatinib	C29H31N7O3	134436906	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1461		Sertraline	C17H17Cl2N	68617	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1463		Sevoflurane	C4H3F7O	5206	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1491		Solifenacin	C23H26N2O2	154059	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1499		Sparfloxacin	C19H22F2N4O3	60464	Major		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57]
D1522		Sunitinib	C22H27FN4O2	5329102	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1542		Telavancin	C80H106Cl2N11O27P	3081362	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1560		Tetrabenazine	C19H27NO3	6018	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1634		Triclabendazole	C14H9Cl3N2OS	50248	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1651		Triptorelin	C64H82N18O13	25074470	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1673		Valbenazine	C24H38N2O4	24795069	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1681		Vandetanib	C22H24BrFN4O2	3081361	Major		Inter Info	[140]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1346		Prochlorperazine	C20H24ClN3S	4917	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1351		Promazine	C17H20N2S	4926	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1361		Protriptyline	C19H21N	4976	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1372		Quinine	C20H24N2O2	3034034	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1383		Ranolazine	C24H33N3O4	56959	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1413		Risperidone	C23H27FN4O2	5073	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1497		Sorafenib	C21H16ClF3N4O3	216239	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1498		Sotalol	C12H20N2O3S	5253	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1526		Tacrolimus	C44H69NO12	445643	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1533		Tamoxifen	C26H29NO	2733526	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1544		Telithromycin	C43H65N5O10	3002190	Major		Inter Info	[30], [165]
D1555		Terfenadine	C32H41NO2	5405	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1612		Toremifene	C26H28ClNO	3005573	Major		Inter Info	[1], [2], [3], [166]
D1616		Tramadol	C16H25NO2	33741	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1624		Trazodone	C19H22ClN5O	5533	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1637		Trifluoperazine	C21H24F3N3S	5566	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1638		Triflupromazine	C18H19F3N2S	5568	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1647		Trimipramine	C20H26N2	5584	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1682		Vardenafil	C23H32N6O4S	135400189	Major		Inter Info	[167]
D1683		Vasopressin	C46H65N15O12S2	644077	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1689		Venlafaxine	C17H27NO2	5656	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1706		Voriconazole	C16H14F3N5O	71616	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1726		Ziprasidone	C21H21ClN4OS	60854	Major		Inter Info	[1], [2], [3], [66], [168], [13]
D0219		Buprenorphine	C29H41NO4	644073	Moderate		Inter Info	[1], [186]
D0498		Dimenhydrinate	C24H28ClN5O3	10660	Moderate		Inter Info	[2], [198], [199], [200]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[2], [3], [212]
D1166		Olanzapine	C17H20N4S	135398745	Moderate		Inter Info	[2], [3], [234]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[2], [3], [236], [237], [238], [239], [240], [241]
D0502		Diphenhydramine	C17H21NO	3100	Moderate		Inter Info	[2], [198], [199], [200]
D1356		Propofol	C12H18O	4943	Moderate		Inter Info	[254], [255], [256], [257], [258], [259], [260], [261], [262], [263]
D1051		Metronidazole	C6H9N3O3	4173	Minor		Inter Info	[2], [275], [276], [277]
D1516		Sulfamethoxazole	C10H11N3O3S	5329	Minor		Inter Info	[1], [2], [3], [281], [282], [283], [284]
	Increased risk of rapid heart rate					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0101		Arbutamine	C18H23NO4	60789	Major		Inter Info	[70], [71], [93]
	Increased risk of ventricular arrhythmias					Drug Num: 40
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0025		Adenosine	C10H13N5O4	60961	Major		Inter Info	[14], [3], [15], [16], [17], [18], [19], [20]
D1185		Orciprenaline	C11H17NO3	4086	Major		Inter Info	[85], [86], [87]
D0107		Arsenic trioxide	As2O3	14888	Major		Inter Info	[94], [95]
D0859		Isoprenaline	C11H17NO3	3779	Major		Inter Info	[85], [86], [87]
D0868		Ivabradine	C27H36N2O5	132999	Major		Inter Info	[3], [109], [110]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Major		Inter Info	[124], [125], [126]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Major		Inter Info	[124], [125], [126]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[2], [138]
D1488		Sodium sulfate	Na2O4S	24436	Major		Inter Info	[124], [125], [126]
D1414		Ritodrine	C17H21NO3	33572	Major		Inter Info	[85], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [153], [154], [155], [156], [157], [158], [86], [159], [160], [161], [162], [87], [163], [164]
D1554		Terbutaline	C12H19NO3	5403	Major		Inter Info	[85], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [153], [154], [155], [156], [157], [158], [86], [159], [160], [161], [162], [87], [163], [164]
D0472		Diatrizoate	C11H9I3N2O4	2140	Moderate		Inter Info	[197]
D0691		Formoterol	C19H24N2O4	3410	Moderate		Inter Info	[85], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [213], [214], [153], [154], [155], [156], [157], [215], [158], [86], [159], [160], [161], [162], [87], [163], [164]
D0854		Isoetharine	C13H21NO3	3762	Moderate		Inter Info	[85], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [213], [214], [153], [154], [155], [156], [157], [215], [158], [86], [159], [160], [161], [162], [87], [163], [164]
D0888		Lactulose	C12H22O11	11333	Moderate		Inter Info	[1], [2], [3], [226], [227], [228]
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[85], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [213], [214], [153], [154], [155], [156], [157], [215], [158], [86], [159], [160], [161], [162], [87], [163], [164]
D0184		Bisacodyl	C22H19NO4	2391	Moderate		Inter Info	[1], [2], [3], [226], [227], [228]
D0269		Castor oil	C57H104O9	14030006	Moderate		Inter Info	[1], [2], [3], [226], [227], [228]
D0701		Frangula purshiana bark	NA	NA	Moderate		Inter Info	[2], [3], [228]
D0731		Glycerin	C3H8O3	753	Moderate		Inter Info	[1], [2], [3], [226], [227], [228]
D0797		Indacaterol	C24H28N2O3	6918554	Moderate		Inter Info	[85], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [213], [214], [153], [154], [155], [156], [157], [215], [158], [86], [159], [160], [161], [162], [87], [163], [164]
D0831		Iodipamide	C20H14I6N2O6	3739	Moderate		Inter Info	[197]
D0832		Iodixanol	C35H44I6N6O15	3724	Moderate		Inter Info	[197]
D0833		Iohexol	C19H26I3N3O9	3730	Moderate		Inter Info	[197]
D0834		Iopamidol	C17H22I3N3O8	65492	Moderate		Inter Info	[197]
D0836		Iopromide	C18H24I3N3O8	3736	Moderate		Inter Info	[197]
D0837		Iothalamic acid	C11H9I3N2O4	3737	Moderate		Inter Info	[70], [197], [71]
D0838		Ioversol	C18H24I3N3O9	3741	Moderate		Inter Info	[197]
D0839		Ioxilan	C18H24I3N3O8	3743	Moderate		Inter Info	[197]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[213], [159], [162]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[1], [2], [3], [226], [227], [228]
D1069		Mineral oil	NA	NA	Moderate		Inter Info	[1], [2], [3], [226], [227], [228]
D1171		Olodaterol	C21H26N2O5	11504295	Moderate		Inter Info	[85], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [213], [214], [153], [154], [155], [156], [157], [215], [158], [86], [159], [160], [161], [162], [87], [163], [164]
D1266		Phenolphthalein	C20H14O4	4764	Moderate		Inter Info	[1], [2], [3], [226], [227], [228]
D1298		Pirbuterol	C12H20N2O3	4845	Moderate		Inter Info	[85], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [213], [214], [153], [154], [155], [156], [157], [215], [158], [86], [159], [160], [161], [162], [87], [163], [164]
D1309		Polyethylene glycol (3350)	C2H6O2	174	Moderate		Inter Info	[2], [3], [228]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[2], [3], [250]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[213], [159], [162]
D1438		Salbutamol	C13H21NO3	2083	Moderate		Inter Info	[145], [151], [156]
D1440		Salmeterol	C25H37NO4	5152	Moderate		Inter Info	[85], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [213], [214], [153], [154], [155], [156], [157], [215], [158], [86], [159], [160], [161], [162], [87], [163], [164]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0562		Eluxadoline	C32H35N5O5	11250029	Moderate		Inter Info	[3], [242]
Pharmacodynamic antagonistic effects
	Antagonize the effect of cholinergic agents					Drug Num: 19
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0175		Bethanechol	C7H17N2O2+	2370	Moderate		Inter Info	[184], [185]
D0256		Carbamoylcholine (ophthalmic)	C6H15N2O2+	2551	Moderate		Inter Info	[187], [188]
D0308		Cevimeline	C10H17NOS	83898	Moderate		Inter Info	[184], [185]
D0440		Demecarium (ophthalmic)	C32H52N4O4+2	5966	Moderate		Inter Info	[187], [188]
D0516		Donepezil	C24H29NO3	3152	Moderate		Inter Info	[201], [202], [203], [204], [205], [206], [207], [208], [209]
D0552		Edrophonium	C10H16NO+	3202	Moderate		Inter Info	[210]
D0707		Galantamine	C17H21NO3	9651	Moderate		Inter Info	[201], [202], [203], [204], [205], [206], [207], [208], [209]
D0746		Guanidine	CH5N3	3520	Moderate		Inter Info	[210]
D0856		Isoflurophate (ophthalmic)	C6H14FO3P	5936	Moderate		Inter Info	[187], [188]
D1285		Physostigmine	C15H21N3O2	5983	Moderate		Inter Info	[201], [202], [203], [204], [205], [206], [207], [208], [209]
D1286		Physostigmine (ophthalmic)	C15H21N3O2	5983	Moderate		Inter Info	[187], [188]
D0015		Acetylcholine	C7H16NO2+	187	Moderate		Inter Info	[187], [188]
D0546		Echothiophate (ophthalmic)	C9H23NO3PS+	10548	Moderate		Inter Info	[187], [188]
D1046		Metoclopramide	C14H22ClN3O2	4168	Moderate		Inter Info	[245], [246]
D1122		Neostigmine	C12H19N2O2+	4456	Moderate		Inter Info	[210]
D1288		Pilocarpine	C11H16N2O2	5910	Moderate		Inter Info	[184], [185]
D1289		Pilocarpine (ophthalmic)	C11H16N2O2	5910	Moderate		Inter Info	[187], [188]
D1365		Pyridostigmine	C9H13N2O2+	4991	Moderate		Inter Info	[210]
D1525		Tacrine	C13H14N2	1935	Moderate		Inter Info	[201], [202], [203], [204], [205], [206], [207], [208], [209]

References
1	Canadian Pharmacists Association.
2	Cerner Multum, Inc. "Australian Product Information.".
3	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
4	Maxa JL, Hebeler RF, Adeeko MA "Torsades de pointes following concurrent amiodarone and levofloxacin therapy." Proc (Bayl Univ Med Cent) 19 (2006): 345-6. [PMID: 17106497]
5	Product Information. Betapace (sotalol). Berlex, Richmond, CA.
6	Product Information. Cordarone (amiodarone). Wyeth-Ayerst Laboratories, Philadelphia, PA.
7	Product Information. Norpace (disopyramide). Searle, Skokie, IL.
8	Product Information. Procan SR (procainamide). Parke-Davis, Morris Plains, NJ.
9	Product Information. Quiniglute (quinidine). Berlex, Richmond, CA.
10	Product Information. Vascor (bepridil). McNeil Pharmaceutical, Raritan, NJ.
11	Trujillo TC, Nolan PE "Antiarrhythmic agents - Drug interactions of clinical significance." Drug Safety 23 (2000): 509-32. [PMID: 11144659]
12	Yamreudeewong W, DeBisschop M, Martin L, Lower D "Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs." Drug Saf 26 (2003): 421-38. [PMID: 12688833]
13	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
14	Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S "Adenosine induced torsades de pointes in a child with congenital long QT syndrome." Pacing Clin Electrophysiol 17 (1994): 1814-7. [PMID: 7838793]
15	Teodorovich N, Margolin E, Kogan Y, Paz O, Swissa M. Torsades de pointes after adenosine administration. J Electrocardiol. 2016;49(2):171-173. [PMID: 26850499]
16	Harrington GR, Froelich EG "Adenosine-induced torsades de pointes." Chest 103 (1993): 1299-1301. [PMID: 8131497]
17	Mallet ML "Proarrhythmic effects of adenosine: a review of the literature." Emerg Med J 21 (2004): 408-10. [PMID: 15208219]
18	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
19	Tachakra SS, Robinson S "Adenosine and cardiac arrhythmias." BMJ 305 (1992): 422. [PMID: 1392935]
20	Wesley RC Jr, Turnquest P "Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome." Am Heart J 123 (1992): 794-6. [PMID: 1539535]
21	Ansari SR, Chopra N "Gatifloxacin and Prolonged QT Interval." Am J Med Sci 327 (2004): 55-6. [PMID: 14722399]
22	Ball P "Quinolone-induced QT interval prolongation: a not-so-unexpected class effect." J Antimicrob Chemother 45 (2000): 557-9. [PMID: 10797074]
23	Bertino JS Jr, Owens RC Jr, Carnes TD, Iannini PB "Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors." Clin Infect Dis 34 (2002): 861-3. [PMID: 11830802]
24	Dale KM, Lertsburapa K, Kluger J, White CM "Moxifloxacin and torsade de pointes." Ann Pharmacother 41 (2007): 336-40. [PMID: 17284508]
25	Demolis JL, Charransol A, Funck-Brentano C, Jaillon P "Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers." Br J Clin Pharmacol 41 (1996): 499-503. [PMID: 8799513]
26	Demolis JL, Kubitza D, Tenneze L, Funck-Bretano C "Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects." Clin Pharmacol Ther 68 (2000): 658-66. [PMID: 11180026]
27	Dupont H, Timsit JF, Souweine B, Gachot B, Wolff M, Regnier B "Torsades de pointe probably related to sparfloxacin." Eur J Clin Microbiol Infect Dis 15 (1996): 350-1. [PMID: 8781892]
28	Falagas ME, Rafailidis PI, Rosmarakis ES "Arrhythmias associated with fluoroquinolone therapy." Int J Antimicrob Agents 29 (2007): 374-9. [PMID: 17241772]
29	Frothingham R "Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin." Pharmacotherapy 21 (2001): 1468-72. [PMID: 11765299]
30	Iannini PB "Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval." Expert Opin Drug Saf 1 (2002): 121-8. [PMID: 12904146]
31	Iannini PB, Circiumaru I "Gatifloxacin-induced QTc prolongation and ventricular tachycardia." Pharmacotherapy 21 (2001): 361-2. [PMID: 11253862]
32	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs." BMJ 322 (2001): 46-7. [PMID: 11141163]
33	Jaillon P, Morganroth J, Brumpt I, Talbot G "Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group." J Antimicrob Chemother 37(suppl a) (1996): 161-7. [PMID: 8737135]
34	Kang J, Wang L, Chen XL, Triggle DJ, Rampe D "Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG." Mol Pharmacol 59 (2001): 122-6. [PMID: 11125032]
35	Katritsis D, Camm AJ "Quinolones: cardioprotective or cardiotoxic." Pacing Clin Electrophysiol 26 (2003): 2317-20. [PMID: 14675020]
36	Lipsky BA, Dorr MB, Magner DJ, Talbot GH "Safety profile of sparfloxacin, a new fluoroquinolone antibiotic." Clin Ther 21 (1999): 148-59. [PMID: 10090432]
37	Makaryus AN, Byrns K, Makaryus MN, Natarajan U, Singer C, Goldner B "Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event?" South Med J 99 (2006): 52-6. [PMID: 16466123]
38	Noel GJ, Natarajan J, Chien S, Hunt TL, Goodman DB, Abels R "Effects of three fluoroquinolones on QT interval in healthy adults after single doses." Clin Pharmacol Ther 73 (2003): 292-303. [PMID: 12709719]
39	Oliphant CM, Green GM "Quinolones: a comprehensive review." Am Fam Physician 65 (2002): 455-64. [PMID: 11858629]
40	Owens RC "QT Prolongation with Antimicrobial Agents : Understanding the Significance." Drugs 64 (2004): 1091-124. [PMID: 15139788]
41	Owens RC "Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes." Pharmacotherapy 21 (2001): 301-19. [PMID: 11253855]
42	Owens RC Jr, Ambrose PG "Torsades de pointes associated with fluoroquinolones." Pharmacotherapy 22 (2002): 663-8 discussion 668-72. [PMID: 12013370]
43	Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
44	Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
45	Product Information. Floxin (ofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
46	Product Information. Levaquin (levofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
47	Product Information. Maxaquin (lomefloxacin). Searle, Skokie, IL.
48	Product Information. Noroxin (norfloxacin). Merck & Co, Inc, West Point, PA.
49	Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
50	Product Information. Zagam (sparfloxacin). Rhone-Poulenc Rorer, Collegeville, PA.
51	Samaha FF "QTC interval prolongation and polymorphic ventricular tachycardia in association with levofloxacin." Am J Med 107 (1999): 528-9. [PMID: 10569314]
52	Siepmann M, Kirch W "Drug points - Tachycardia associated with moxifloxacin." Br Med J 322 (2001): 23. [PMID: 11141146]
53	Stahlmann R "Clinical toxicological aspects of fluoroquinolones." Toxicol Lett 127 (2002): 269-77. [PMID: 12052667]
54	Thomas M, Maconochie JG, Fletcher E "The dilemma of the prolonged QT interval in early drug studies." Br J Clin Pharmacol 41 (1996): 77-81. [PMID: 8838432]
55	Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF "Effects of three fluoroquinolones on QT analysis after standard treatment courses." Ann Noninvasive Electrocardiol 11 (2006): 52-6. [PMID: 16472283]
56	White CM, Grant EM, Quintiliani R "Moxifloxacin does increase the corrected QT interval." Clin Infect Dis 33 (2001): 1441-2. [PMID: 11565091]
57	Zix JA, GeerdesFenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
58	Product Information. Propulsid (cisapride). Janssen Pharmaceutica, Titusville, NJ.
59	Trinkle R "Comment: syncopal episodes associated with cisapride." Ann Pharmacother 33 (1999): 251. [PMID: 10084425]
60	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide).".
61	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
62	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod).".
63	Product Information. Leustatin (cladribine). Ortho Biotech Inc, Raritan, NJ.
64	Product Information. Clozaril (clozapine). Novartis Pharmaceuticals, East Hanover, NJ.
65	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
66	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
67	Product Information. Inapsine (droperidol). Janssen Pharmaceutica, Titusville, NJ.
68	Lode H, Vogel F, Elies W "Grepafloxacin: A review of its safety profile based on clinical trials and postmarketing surveillance." Clin Ther 21 (1999): 61-74. [PMID: 10090425]
69	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
70	Ace LN, Jaffe JM, Kunka RL "Effect of food and an antacid on quinidine bioavailability." Biopharm Drug Dispos 4 (1983): 183-90. [PMID: 6882885]
71	Min DI, Ku YM, Geraets DR, Lee HC "Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers." J Clin Pharmacol 36 (1996): 469-76. [PMID: 8739026]
72	Product Information. Corvert (ibutilide). Pharmacia and Upjohn, Kalamazoo, MI.
73	Product Information. Serentil (mesoridazine) Boehringer-Ingelheim, Ridgefield, CT.
74	De Bels D, Staroukine M, Devriendt J "Torsades de pointes due to methadone." Ann Intern Med 139 (2003): E156. [PMID: 12859181]
75	Ehret GB, Desmeules JA, Broers B "Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology." Expert Opin Drug Saf 6 (2007): 289-303. [PMID: 17480178]
76	Gil M, Sala M, Anguera I, et al. "QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone." Am J Cardiol 92 (2003): 995-7. [PMID: 14556883]
77	Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS "Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes." Pharmacotherapy 23 (2003): 802-5. [PMID: 12820821]
78	Krantz MJ, Lewkowiez L, Hays H, et al "Torsade de pointes associated with very-high-dose methadone." Ann Intern Med 137 (2002): 501-4. [PMID: 12230351]
79	Krantz MJ, Mehler PS "Synthetic opioids and QT prolongation." Arch Intern Med 163 (2003): 1615 author reply 1615. [PMID: 12860589]
80	Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN "Impact of methadone treatment on cardiac repolarization and conduction in opioid users." Am J Cardiol 95 (2005): 915-8. [PMID: 15781034]
81	Mokwe EO, Ositadinma O "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966000]
82	Sala M, Anguera I, Cervantes M "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966001]
83	Walker PW, Klein D, Kasza L "High dose methadone and ventricular arrhythmias: a report of three cases." Pain 103 (2003): 321-4. [PMID: 12791438]
84	Product Information. Korlym (mifepristone). Corcept Therapeutics Incorporated, Menlo Park, CA.
85	Bengtsson B, Fagerstrom PO "Extrapulmonary effects of terbutaline during prolonged administration." Clin Pharmacol Ther 31 (1982): 726-32. [PMID: 7042176]
86	Rakhmanina NY, Kearns GL, Farrar HC "Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler." Pediatr Emerg Care 14 (1998): 145-7. [PMID: 9583400]
87	Windom H, Grainger J, Burgess C, Crane J, Pearce N, Beasley R "A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol." N Z Med J 103 (1990): 259-61. [PMID: 1972557]
88	Product Information. Definity (perflutren). Lantheus Medical Imaging Inc, North Billerica, MA.
89	Product Information. Optison (perflutren). Mallinckrodt Medical Inc, St. Louis, MO.
90	Windle J, Prystowsky EN, Miles WM, Heger JJ "Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide." Clin Pharmacol Ther 41 (1987): 603-10.[PMID: 3581646]
91	Saal AK, Werner JA, Greene HL, Sears GK, Graham EL "Effect of amiodarone on serum quinidine and procainamide levels." Am J Cardiol 53 (1984): 1264-7.[PMID: 6711425]
92	Lesko LJ "Pharmacokinetic drug interactions with amiodarone." Clin Pharmacokinet 17 (1989): 130-40.[PMID: 2673606]
93	Product Information. GenESA (arbutamine). Gensia Inc, San Diego, CA.
94	Ohnishi K, Yoshida H, Shigeno K, et al. "Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia." Ann Intern Med 133 (2000): 881-5. [PMID: 11103058]
95	Product Information. Trisenox (arsenic trioxide) Cephalon Inc, West Chester, PA.
96	Product Information. Olumiant (baricitinib). Lilly, Eli and Company, Indianapolis, IN.
97	Hollingshead LM, Faulds D, Fitton A "Bepridil. A review of its pharmacological properties and therapeutic use in stable angina pectoris." Drugs 44 (1992): 835-57. [PMID: 1280569]
98	Product Information. Ferriprox (deferiprone). ApoPharma USA Inc, Rockville, MD.
99	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports."
100	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
101	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
102	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod)."
103	Abernethy DR, Wesche DL, Barbey JT, et al. "Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation." Br J Clin Pharmacol 51 (2001): 231-7. [PMID: 11298069]
104	Giao PT, de Vries PJ "Pharmacokinetic interactions of antimalarial agents." Clin Pharmacokinet 40 (2001): 343-73. [PMID: 11432537]
105	Nosten F, ter Kuile FO, Luxemburger C, et al "Cardiac effects of antimalarial treatment with halofantrine." Lancet 341 (1993): 1054-6. [PMID: 8096959]
106	Product Information. Halfan (halofantrine). GlaxoSmithKline, Philadelphia, PA.
107	Product Information. Lariam (mefloquine). Roche Laboratories, Nutley, NJ.
108	Sudden death in a traveler following halofantrine administration--Togo, 2000. MMWR Morb Mortal Wkly Rep 50 (2001): 169-70, 179. [PMID: 11393488]
109	Mittal SR "Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine." J Assoc Physicians India 62 (2014): 426-7. [PMID: 25438492]
110	Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
111	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
112	Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
113	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
114	Product Information. Macrilen (macimorelin). Aeterna Zentaris, Charleston, SC.
115	Martin DE, Shen J, Griener J, Raasch R, Patterson JH, Cascio W "Effects of ofloxacin on the pharmacokinetics and pharmacodynamics of procainamide." J Clin Pharmacol 36 (1996): 85-91. [PMID: 8932548]
116	Goto M, Sato M, Kitzazawa H, et.al "Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation." Intern Med 53 (2014): 1629-31. [PMID: 25088875]
117	Inoue T, Asahi S, Takayanagi K, Morooka S, Takabatake Y "QT prolongation and possibility of ventricular arrhythmias after intracoronary papaverine." Cardiology 84 (1994): 9-13. [PMID: 7511988]
118	Jain A, Jenkins MG "Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine." Cathet Cardiovasc Diagn 18 (1989): 255-7. [PMID: 2605630]
119	Kern MJ, Deligonul U, Serota H, Gudipati C, Buckingham T "Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve." Cathet Cardiovasc Diagn 19 (1990): 229-36. [PMID: 2334953]
120	Nakayama M, Saito A, Kitazawa H, et.al "Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases." Intern Med 51 (2012): 351-6. [PMID: 22333368]
121	Nakayama M, Tanaka N, Sakoda K, et.al "Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease." Circ J 79 (2015): 530-6. [PMID: 25746536]
122	Talman CL, Winniford MD, Rossen JD, Simonetti I, Kienzle MG, Marcus ML "Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine." J Am Coll Cardiol 15 (1990): 275-8. [PMID: 2299067]
123	Vrolix M, Piessens J, De Geest H "Torsades de pointes after intracoronary papaverine." Eur Heart J 12 (1991): 273-6. [PMID: 2044564]
124	Hill AG, Parry BR "Hypokalaemia following bowel cleansing with sodium phosphate." N Z Med J 109 (1996): 347. [PMID: 8862361]
125	Product Information. Suclear (polyethylene glycol 3350 with electrolytes). Braintree Laboratories, Braintree, MA.
126	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
127	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
128	Buss J, Neuss H, Bilgin Y, Schlepper M "Malignant ventricular tachyarrhythmias in association with propafenone treatment." Eur Heart J 6 (1985): 424-8. [PMID: 4043097]
129	Hii JT, Wyse DG, Gillis AM, et al "Propafenone-induced torsade de pointes: cross-reactivity with quinidine." Pacing Clin Electrophysiol 14 (1991): 1568-70. [PMID: 1721143]
130	Klein RC, Huang SK, Marcus FI, et al "Enhanced antiarrhythmic efficacy of propafenone when used in combination with procainamide or quinidine." Am Heart J 114 (1987): 551-8. [PMID: 3630896]
131	Product Information. Rhythmol (propafenone). Knoll Pharmaceutical Company, Whippany, NJ.
132	Product Information. Rythmol SR (propafenone). GlaxoSmithKline, Research Triangle Park, NC.
133	Zehender M, Hohnloser S, Geibel A, et al "Short-term and long-term treatment with propafenone: determinants of arrhythmia suppression, persistence of efficacy, arrhythmogenesis, and side effects in patients." Br Heart J 67 (1992): 491-7. [PMID: 1622701]
134	Anson BD, Weaver JG, Ackerman MJ, et al. "Blockade of HERG channels by HIV protease inhibitors." Lancet 365 (2005): 682-686. [PMID: 15721475]
135	Biondi L "Health Canada endorsed important safety information on Invirase (saquinavir mesylate)." .
136	Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
137	FDA. U.S. Food and Drug Administration "FDA drug safety communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms.".
138	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
139	Product Information. Rinvoq (upadacitinib). AbbVie US LLC, North Chicago, IL.
140	Product Information. Vandetanib (vandetanib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
141	Braden GL, vonOeyen PT, Germain MJ, Watson DJ, Haag BL "Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences." Kidney Int 51 (1997): 1867-75. [PMID: 9186877]
142	Clifton GD, Hunt BA, Patel RC, Burki NK "Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses." Am Rev Respir Dis 141 (1990): 575-9. [PMID: 2178522]
143	Dickens GR, Mccoy RA, West R, Stapczynski JS, Clifton GD "Effect of nebulized albuterol on serum potassium and cardiac rhythm in patients with asthma or chronic obstructive pulmonary disease." Pharmacotherapy 14 (1994): 729-33. [PMID: 7885977]
144	Ferguson GT, Funck-Brentano C, Fischer T, Darken P, Reisner C "Cardiovascular Safety of Salmeterol in COPD." Chest 123 (2003): 1817-24. [PMID: 12796155]
145	Gelmont DM, Balmes JR, Yee A "Hypokalemia induced by inhaled bronchodilators." Chest 94 (1988): 763-6. [PMID: 3168573]
146	Gross TL, Sokol RJ "Severe hypokalemia and acidosis: a potential complication of beta- adrenergic treatment." Am J Obstet Gynecol 138 (1980): 1225-6. [PMID: 7446635]
147	Hastwell G, Lambert BE "The effect of oral salbutamol on serum potassium and blood sugar." Br J Obstet Gynaecol 85 (1978): 767-9. [PMID: 708661]
148	Hurlbert BJ, Edelman JD, David K "Serum potassium levels during and after terbutaline." Anesth Analg 60 (1981): 723-5. [PMID: 7197475]
149	Hypokalaemia due to salbutamol overdosage. Br Med J (Clin Res Ed) 283 (1981): 500-1. [PMID: 6114774]
150	Kantola I, Tarssanen L "Hypokalemia from usual salbutamol dosage ." Chest 89 (1986): 619-20. [PMID: 3956296]
151	Lowe MD, Rowland E, Brown MJ, Grace AA "Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium." Heart 86 (2001): 45-51. [PMID: 11410561]
152	Milic M, Bao X, Rizos D, Liu F, Ziegler MG "Literature review and pilot studies of the effect of qt correction formulas on reported beta(2)-agonist-induced QTc prolongation." Clin Ther 28 (2006): 582-90. [PMID: 16750469]
153	Product Information. Brovana (arformoterol). Sepracor Inc, Marlborough, MA.
154	Product Information. Foradil (formoterol) Novartis Pharmaceuticals, East Hanover, NJ.
155	Product Information. Maxair (pirbuterol). 3M Pharmaceuticals, St. Paul, MN.
156	Product Information. Proventil (albuterol). Schering Laboratories, Kenilworth, NJ.
157	Product Information. Severent (salmeterol). Glaxo Wellcome, Research Triangle Park, NC.
158	Product Information. Xopenex (levalbuterol). Sepracor, Marlborough, MA.
159	Sanders JP, Potter DE, Ellis S, Bee DE, Grant JA "Metabolic and cardiovascular effects of carbuterol and metaproterenol." J Allergy Clin Immunol 60 (1977): 174-9. [PMID: 19514]
160	Sun ZH, Swan H, Vitasalo M, Toivonen L "Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome." J Am Coll Cardiol 31 (1998): 1400-5. [PMID: 9581741]
161	Tveskov C, Djurhuus MS, Klitgaard NAH, Egstrup K "Potassium and magnesium distribution, ECG changes, and ventricular ectopic beats during beta(2)-adrenergic stimulation with terbutaline in healthy subjects." Chest 106 (1994): 1654-9. [PMID: 7988180]
162	Whyte KF, Addis GJ, Whitesmith R, Reid JL "The mechanism of salbutamol-induced hypokalaemia." Br J Clin Pharmacol 23 (1987): 65-71. [PMID: 3545273]
163	Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE "Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma." Lancet 336 (1990): 1396-9. [PMID: 1978872]
164	Larsson S, Svedmyr N "Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol inasthmatics." Am Rev Respir Dis 116 (1977): 861-9. [PMID: 921062]
165	Product Information. Ketek (telithromycin). Aventis Pharmaceuticals, Bridgewater, NJ.
166	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
167	Product Information. Levitra (vardenafil). Bayer, West Haven, CT.
168	Product Information. Geodon (ziprasidone). Pfizer US Pharmaceuticals, New York, NY.
169	Product Information. Actemra (tocilizumab). Genentech, South San Francisco, CA.
170	Product Information. Amevive (alefacept). Biogen, Cambridge, MA.
171	Product Information. Arcalyst (rilonacept). Regeneron Pharmaceuticals Inc, Tarrytown, NY.
172	Product Information. Cosentyx (secukinumab). Novartis Pharmaceuticals, East Hanover, NJ.
173	Product Information. Gamifant (emapalumab). Sobi Inc, Ardmore, PA.
174	Product Information. Ilaris (canakinumab). Novartis Pharmaceuticals, East Hanover, NJ.
175	Product Information. Ilumya (tildrakizumab). Merck & Company Inc, Whitehouse Station, NJ.
176	Product Information. Kevzara (sarilumab). sanofi-aventis, Bridgewater, NJ.
177	Product Information. Remicade (infliximab). Centocor Inc, Malvern, PA.
178	Product Information. Simponi (golimumab). Centocor Inc, Malvern, PA.
179	Product Information. Skyrizi (risankizumab). AbbVie US LLC, North Chicago, IL.
180	Product Information. Stelara (ustekinumab). Centocor Inc, Malvern, PA.
181	Product Information. Sylvant (siltuximab). Janssen Biotech, Inc., Horsham, PA, PA.
182	Product Information. Taltz Autoinjector (ixekizumab). Eli Lilly and Company, Indianapolis, IN.
183	Product Information. Campath (alemtuzumab) Berlex, Richmond, CA.
184	Benjamin KW "Toxicity of ocular medications." Int Ophthalmol Clin 19 (1979): 199-255. [PMID: 376469]
185	Product Information. Salagen Tablets (pilocarpine). Boehringer-Ingelheim, Ridgefield, CT.
186	Product Information. Butrans (buprenorphine). Purdue Pharma LP, Stamford, CT.
187	Multum Information Services, Inc. Expert Review Panel.
188	Product Information. Pilopine HS (pilocarpine ophthalmic). Alcon Laboratories Inc, Fort Worth, TX.
189	Bauer LA, Black D, Gensler A "Procainamide-cimetidine drug interaction in elderly male patients." J Am Geriatr Soc 38 (1990): 467-9. [PMID: 2329253]
190	Christian CD, Meredith CG, Speeg KV "Cimetidine inhibits renal procainamide clearance." Clin Pharmacol Ther 36 (1984): 221-7. [PMID: 6204803]
191	Higbee MD, Wood JS, Mead RA "Procainamide-cimetidine interaction: a potential toxic interaction in the elderly." J Am Geriatr Soc 32 (1984): 162-4. [PMID: 6693705]
192	Lai MY, Jiang FM, Chung CH, et al "Dose dependent effect of cimetidine on procainamide disposition in man." Int J Clin Pharmacol Ther Toxicol 26 (1988): 118-21. [PMID: 2457561]
193	Rodvold KA, Paloucek FP, Jung D, Gallastegui J "Interaction of steady-state procainamide with H2-receptor antagonists cimetidine and ranitidine." Ther Drug Monit 9 (1987): 378-83. [PMID: 2447687]
194	Somogyi A, McLean A, Heinzow B "Cimetidine-procainamide pharmacokinetic interaction in man: evidence of competition for tubular secretion of basic drugs." Eur J Clin Pharmacol 25 (1983): 339-45. [PMID: 6194997]
195	Product Information. Anectine (succinylcholine). Glaxo Wellcome, Research Triangle Park, NC.
196	Product Information. Welchol (colesevelam) Daiichi Sankyo, Inc., Parsippany, NJ.
197	Goernig M, Kirmeier T, Krack A, Hartog CS, Figulla HR, Leder U "Iohexol contrast medium induces QT prolongation in amiodarone patients." Br J Clin Pharmacol 58 (2004): 96-98. [PMID: 15206999]
198	Husain Z, Hussain K, Nair R, Steinman R "Diphenhydramine induced QT prolongation and torsade de pointes: An uncommon effect of a common drug." Cardiology 17 (2010): 509-11. [PMID: 20865683]
199	Poluzzi E, Raschi E, Godman B, et.al "Pro-arrhythmic potential of oral antihistamines (H1): Combining adverse event reports with drug utilization data across Europe." PLoS One 10 (2014): epub. [PMID: 25785934]
200	Shah A, Yousuf T, Ziffra J, Zaidi A, Raghuvir R "Diphenhydramine and QT prolongation - A rare cardiac side effect of a drug used in common practice." J Cardiol Cases 12 (2015): 126-9. [PMID: 30546575]
201	Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC "Explicit criteria for determining inappropriate medication use in nursing home residents." Arch Intern Med 151 (1991): 1825-32. [PMID: 1888249]
202	Carnahan RM, Lund BC, Perry PJ, Chrischilles EA "The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice?" J Am Geriatr Soc 52 (2004): 2082-7. [PMID: 15571547]
203	Edwards KR, O'Connor JT "Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors." J Am Geriatr Soc 50 (2002): 1165-6. [PMID: 12110086]
204	Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH "Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts." Arch Intern Med 163 (2003): 2716-2724. [PMID: 14662625]
205	Katz IR, Sands LP, Bilker W, DiFilippo S, Boyce A, D'Angelo K "Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride." J Am Geriatr Soc 46 (1998): 8-13. [PMID: 9434659]
206	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
207	Product Information. Cognex (tacrine). Parke-Davis, Morris Plains, NJ.
208	Product Information. Reminyl (galantamine) Janssen Pharmaceuticals, Titusville, NJ.
209	Roe CM, Anderson MJ, Spivack B "Use of anticholinergic medications by older adults with dementia." J Am Geriatr Soc 50 (2002): 836-42. [PMID: 12028169]
210	Product Information. Mestinon (pyridostigmine). ICN Pharmaceuticals Inc, Cost Mesa, CA.
211	Product Information. Baraclude (entecavir). Bristol-Myers Squibb, Princeton, NJ.
212	Product Information. Pepcid (famotidine). Merck & Co, Inc, West Point, PA.
213	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
214	Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
215	Product Information. Striverdi Respimat (olodaterol). Boehringer Ingelheim, Ridgefield, CT.
216	Product Information. Cytovene (ganciclovir). Genentech, South San Francisco, CA.
217	Product Information. Valcyte (valganciclovir) Roche Laboratories, Nutley, NJ.
218	Product Information. Anoro Ellipta (umeclidinium-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
219	Product Information. Combivent (albuterol-ipratropium). Boehringer-Ingelheim, Ridgefield, CT.
220	Product Information. Qbrexza (glycopyrrolate topical). Dermira, Inc., Menlo Park, CA.
221	Cole JM, Sheehan AH, Jordan JK "Concomitant use of ipratropium and tiotropium in chronic obstructive plmonary disease." Ann Pharmacother 46 (2012): 1717-21. [PMID: 23170031]
222	Product Information. Atrovent (ipratropium). Boehringer-Ingelheim, Ridgefield, CT.
223	Product Information. Spiriva (tiotropium). Boehringer Ingelheim, Ridgefield, CT.
224	Product Information. Tudorza Pressair (aclidinium). Forest Pharmaceuticals, St. Louis, MO.
225	Product Information. Yupelri (revefenacin). Mylan Specialty, Morgantown, WV.
226	Chin RL "Laxative-induced hypokalemia." Ann Emerg Med 32 (1998): 517-8. [PMID: 9774942]
227	Muller-Lissner SA "Adverse effects of laxatives: fact and fiction." Pharmacology 47 (1993): 138-45. [PMID: 8234421]
228	Schaefer DC, Cheskin LJ "Constipation in the elderly." Am Fam Physician 58 (1998): 907-14. [PMID: 9767726]
229	Eronen M, Putkonen H, Hallikainen T, Vartiainen H "Lethal gastroenteritis associated with clozapine and loperamide." Am J Psychiatry 160 (2003): 2242-2243. [PMID: 14638602]
230	Product Information. Glucophage (metformin). Bristol-Myers Squibb, Princeton, NJ.
231	Somogyi A, Stockley C, Keal J, Rolan P, Bochner F "Reduction of metformin renal tubular secretion by cimetidine in man." Br J Clin Pharmacol 23 (1987): 545-51. [PMID: 3593625]
232	Product Information. Sandostatin (octreotide). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
233	Product Information. Somatuline Depot (lanreotide). Ipsen Inc, Milford, MA.
234	Product Information. Zyprexa (olanzapine). Lilly, Eli and Company, Indianapolis, IN.
235	Product Information. Alimta (pemetrexed). Lilly, Eli and Company, Indianapolis, IN.
236	Goodnick PJ, Jerry J, Parra F "Psychotropic drugs and the ECG: focus on the QTc interval." Expert Opin Pharmacother 3 (2002): 479-98. [PMID: 11996627]
237	Kane JM, Carson WH, Saha AR, et al. "Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder." J Clin Psychiatry 63 (2002): 763-71. [PMID: 12363115]
238	Keck PE Jr, Marcus R, Tourkodimitris S, et al. "A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania." Am J Psychiatry 160 (2003): 1651-8. [PMID: 12944341]
239	Nelson S, Leung JG "Torsades de Pointes After Administration of Low-Dose Aripiprazole (February)." Ann Pharmacother (2013):. [PMID: 23362038]
240	Pigott TA, Carson WH, Saha AR, Torbeyns AF, Stock EG, Ingenito GG "Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study." J Clin Psychiatry 64 (2003): 1048-56. [PMID: 14628980]
241	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
242	Product Information. Viberzi (eluxadoline). Actavis Pharma, Inc., Parsippany, NJ.
243	Product Information. Indium Oxyquinoline In-111 (indium oxyquinoline In-111). GE Healthcare, Princeton, NJ.
244	Product Information. Vimpat (lacosamide). UCB Pharma Inc, Smyrna, GA.
245	Product Information. Motilium (domperidone). Janssen-Ortho Inc, Toronto, ON.
246	Product Information. Reglan (metoclopramide). Wyeth-Ayerst Laboratories, Philadelphia, PA.
247	Product Information. Ocrevus (ocrelizumab). Genentech, South San Francisco, CA.
248	Product Information. Synribo (omacetaxine). Teva Pharmaceuticals USA, North Wales, PA.
249	Product Information. Xofigo (radium Ra 223 dichloride). Bayer Pharmaceutical Inc, West Haven, CT.
250	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
251	Nuclear Pharmacy Website. University of Arkansas for Medical Sciences. College of Pharmacy "Drug - Radiopharmaceutical Interactions. Available from: URL: http://nuclearpharmacy.uams.edu/nicki.html#tl.".
252	Product Information. Thallous Chloride Tl 201 (thallous chloride Tl-201). GE Healthcare, Princeton, NJ.
253	Canadian Pharmacists Association "e-CPS."
254	Hanci V, Aydin M, Yurtlu BS, et.al "Anesthesia induction with sevoflurane and propofol: evaluation of P-wave dispersion, QT and corrected QT intervals." Kaohsiung J Med Sci 26 (2010): 470-7. [PMID: 20837343]
255	Kim DH, Kweon TD, Nam SB, Han DW, Cho WY, Lee JS "Effects of target concentration infusion of propofol and tracheal intubation on QTc interval." Anaesthesia 63 (2008): 1061-4. [PMID: 18717665]
256	Kleinsasser A, Kuenszberg E, Loeckinger A, et.al "Sevoflurane, but not propofol, significantly prolongs the Q-T interval." Anesth Analg 90 (2000): 25-7. [PMID: 10624970]
257	Kleinsasser A, Loeckinger A, Lindner KH, Keller C, Boehler M, Puehringer F "Reversing sevoflurane-associated Q-Tc prolongation by changing to propofol." Anaesthesia 56 (2001): 248-50. [PMID: 11251432]
258	Paventi S, Santevecchi A, Ranieri R "Effects of sevoflurane versus propofol on QT interval." Minerva Anestesiol 67 (2001): 637-40. [PMID: 11731753]
259	Scalese MJ, Herring HR, Rathburn RC, Skrepnek GH, Ripley TL "Propofol-associated QTc prolongation." Ther Adv Drug Saf 7 (2016): 68-78. [PMID: 27298717]
260	Staikou C, Stamelos M, Stavroulakis E "Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity." Br J Anaesth 112 (2014): 217-30. [PMID: 24305646]
261	Toyoda T, Terao Y, Oji M, Okada M, Fukusaki M, Sumikawa K "The interaction of antiemetic dose of droperidol with propofol on QT interval during anesthetic induction." J Anesth 27 (2013): 885-9. [PMID: 23660990]
262	Whyte SD, Booker PD, Buckley DG "The Effects of Propofol and Sevoflurane on the QT Interval and Transmural Dispersion of Repolarization in Children." Anesth Analg 100 (2005): 71-77. [PMID: 15616054]
263	Wutzler A, De Asmundis C, Matsuda H, et.al "Effects of propofol on ventricular repolarization and incidence of malignant arrhythmias in adults." J Electrocardiol 51 (2018): 170-4. [PMID: 29174097]
264	Martin BK "Effect of ranitidine on procainamide disposition." Br J Clin Pharmacol 19 (1985): 858-60. [PMID: 4027133]
265	Rocci ML, Kosoglou T, Ferguson RK, Vlasses PH "Ranitidine-induced changes in the renal and hepatic clearances of procainamide are correlated." J Pharmacol Exp Ther 248 (1989): 923-8. [PMID: 2467982]
266	Somogyi A, Bochner F "Dose and concentration dependent effect of ranitidine on procainamide disposition and renal clearance in man." Br J Clin Pharmacol 18 (1984): 175-81. [PMID: 6091709]
267	Harron D, Brogden R "Acecaindie (N-acetylprocainamide)." Drugs 39 (1990): 720-40
268	Kosoglou T, Rocci M, Vlasses P "Trimethoprim alters the disposition of procainamide and N-acetylprocainamide." Clin Pharmacol Ther 44 (1988): 467-77
269	Vlasses P, Kosoglou T, Chase S, et al "Trimethoprim inhibition of the renal clearance of procainamide and N-acetylprocainamide." Arch Intern Med 149 (1989): 1350-3
270	Product Information. Sanctura (trospium chloride). Odyssey Pharmaceutical, East Hanover, NJ.
271	Product Information. Lotronex (alosetron). Glaxo Wellcome, Research Triangle Park, NC.
272	Gilman AG, Rall TW, Nies AS, Taylor P, eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 8th ed." New York, NY: Pergamon Press Inc. (1990):.
273	Product Information. Atrovent nasal spray (ipratropium nasal). Boehringer-Ingelheim, Ridgefield, CT.
274	Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
275	Kounas SP, Letsas KP, Sideris A, Efraimidis M, Kardaras F "QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone." Pacing Clin Electrophysiol 28 (2005): 472-3. [PMID: 15869686]
276	Product Information. Flagyl (metronidazole). Searle, Skokie, IL.
277	Product Information. Pylera (bismuth subcitrate potassium/metronidazo/TCN). Aptalis Pharma, Birmingham, AL.
278	Product Information. ProAmatine (midodrine). Roberts Pharmaceutical Corporation, Eatontown, NJ.
279	Product Information. Namenda (memantine). Forest Pharmaceuticals, St. Louis, MO.
280	Cuthbert MF "The effect of quinidine and procainamide on the neuromuscular blocking action of suxamethonium." Br J Anaesth 38 (1966): 775-9
281	Crouch MA, Limon L, Cassano AT "Clinical relevance and management of drug-related QT interval prolongation." Pharmacotherapy 23 (2003): 881-908. [PMID: 12885102]
282	Darpo B "Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes." Eur Heart J Suppl 3(Suppl K) (2001): K70-80.
283	Lopez JA, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T "QT prolongation and torsades de pointes after administration of trimethoprin-sulfamethoxazole." Am J Cardiol 59 (1987): 376-7. [PMID: 3492908]
284	Wiener I, Rubin D, Martinez E, et al "QT prolongation and paroxysmal ventricular tachycardia occurring during fever following trimethoprim-sulfamethoxazole administration." Mt Sinai J Med 48 (1981): 53-5. [PMID: 6970886]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence